Everolimus - Moligand™, ≥98% , FK506-binding protein 1A inhibitor, CAS No.159351-69-6, FK506-binding protein 1A inhibitor
En stock
SKU
E125341
Potent mTOR inhibitor
"}
Potent mTOR inhibitor
Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.
An immunosuppresive inhibitor of FRAP (mTOR).
| CAS | 159351-69-6 |
|---|---|
| Synonymes | EVEROLIMUS (USP-RS) | EVEROLIMUS [MI] | Votubia | 5-methyl-5-phenyl-barbituric acid | DTXCID8020599 | EVEROLIMUS [VANDF] | Everolimus tablets | RAD, SDZ | AKOS015907063 | L04AA18 | SDZ RAD | UNII-9HW64Q8G6G | Tox21_112510 | (3S,6R,7E,9R,10R,12R,14S,15E,17 |
| Spécifications et pureté | Moligand™, ≥98% |
| Conditions de stockage de stockage | Store at -20°C |
| Expédié en | Ice chest + Ice pads |
| Product Description | Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM. |
| Pubchem Sid | 488195795 |
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488195795 |
| Solubilité | Soluble in chloroform, methanol, DMSO (100 mg/ml), water (<1 mg/ml at 25 °C), and ethanol (100 mg/ml). |
| Cible | MTOR |
| Numéro CE | 621-003-9 |
| PubChem CID | 6442177 |
| Formule moléculaire | C53H83NO14 |
À partir de 49,90 $US